XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

Note 7: Income Taxes


Income tax expense from continuing operations consists of the following:


 

 

December 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Current income tax expense/(benefit)

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

 

 

 

 

Total current income tax expense/(benefit)

 

 

 

 

 

 

Deferred income tax expense/(benefit)

 

 

 

 

 

 

 

 

Federal

 

 

(840,812

)

 

 

27,096

 

State

 

 

(146,541

)

 

 

4,811

 

Total deferred tax expense/(benefit)

 

 

(987,353

)

 

 

31,907

 

 

 

 

 

 

 

 

 

 

Total income tax expense/(benefit)

 

 

(987,353

)

 

 

31,907

 


Items accounting for the differences between income taxes at statutory income tax rates and the actual effective rate are as follows:


Year Ended December 31,

 

2020

 

 

2019

 

Federal Statutory Rate

 

 

21.00

%

 

 

21.00

%

Effective State Rate

 

 

3.66

%

 

 

3.66

%

Incentive Stock Options

 

 

-2.01

%

 

 

-1.81

%

PPP Forgiveness

 

 

0.68

%

 

 

0.00

%

Officers Life Insurance

 

 

-0.01

%

 

 

-0.04

%

Meals And Entertainment

 

 

0.00

%

 

 

-0.01

%

Organizational Costs

 

 

0.00

%

 

 

0.00

%

R&D Credit

 

 

0.91

%

 

 

4.61

%

Change In Valuation Allowance

 

 

11.57

%

 

 

-25.96

%

Prior Year Adjustments

 

 

0.91

%

 

 

-4.09

%

Other

 

 

-0.14

%

 

 

-1.55

%

Effective Rate

 

 

36.57

%

 

 

-4.19

%


The components of deferred income tax assets and liabilities were as follows:


 

 

December 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Deferred tax assets

 

 

 

 

 

 

 

 

Loss carryforwards

 

 

2,585,042

 

 

 

1,933,118

 

Marketable securities

 

 

 

 

 

121,212

 

Non-qualified stock options

 

 

 

 

 

 

R&D Credits

 

 

378,524

 

 

 

329,186

 

Less valuation allowance

 

 

(2,060,283

)

 

 

(2,372,656

)

Deferred tax assets

 

 

903,283

 

 

 

10,860

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

Depreciation/amortization

 

 

(6,087

)

 

 

(10,860

)

Intangible assets

 

 

(897,196

)

 

 

(987,353

)

Deferred tax liabilities

 

 

(903,283

)

 

 

(998,213

)

 

 

 

 

 

 

 

 

 

Totals

 

 

 

 

 

(987,353

)


The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse.


The Company records a valuation allowance for certain temporary differences for which it is more likely than not that it will not receive future tax benefits. The Company assesses its past earnings history and trends and projections of future net income. The Company recorded a valuation allowance for the entire amount of the net deferred tax asset at December 31, 2020 and 2019.  The change in the valuation allowance during the years ended December 31, 2020 and 2019 was an  increase/(decrease) of ($312,000) and $198,000, respectively. The Company will continue to review this valuation allowance and make adjustments as appropriate.


As of December 31, 2020 and 2019, the Company maintained net operating loss (“NOL”) carryforwards of approximately $10,483,000 and $7,839,000. Use of NOL carryforwards are limited by the provisions of Section 382 of the Internal Revenue Code. At this point, the Company has not performed an analysis to determine whether an ownership change (as defined under Section 382) occurred during this year or preceding year(s). A determination of the potential impact these provisions might have on the utilization of net operating losses will be made when the net operating loss is projected to be utilized. The NOL carryforwards expire at various intervals through 2037, except the NOLs from tax years beginning after December 31, 2017, which have no expiration date. In addition, the Company has R&D credits of $379,000 that will expire at various intervals through 2039.


The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740 states that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. At this time, the Company does not have any uncertain tax positions to assess.